BeOne Medicines
The Global HEOR/RWE Senior Director provides strategic leadership for health economics and real-world evidence activities supporting BRUKINSA across hematology indications and lifecycle management. This role involves developing integrated value evidence generation strategies to strengthen the product's value proposition and support medical, regulatory, and reimbursement needs across key markets. The position serves as a cross-functional partner to ensure aligned evidence generation and drive results in a matrix environment.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1-10 employees
Founded
2010
BeOne Medicines, formerly BeiGene, is committed to advancing cancer care through a science‑led, purpose‑driven model that improves treatment access for patients worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BeOne Medicines.
14% above the average for this role
Senior Director, Global Health Economic & Outcomes Research / Real World
lifelancer
Director, Health Economics and Outcomes Research (HEOR)
Corcept Therapeutics
Director, HEOR & RWE, Europe
Revolution Medicines
Global Real-World Evidence & Health Economics & Outcomes Research (RWE & HEOR) Lead
Takeda Pharmaceuticals Korea Co., Ltd.
Senior Manager, HEOR/RWE, Voranigo
Servier
Director HEOR and RWE
Zealand Pharma